News
QbD Pharmaceuticals Launches TETREN — Nepal’s First National Brand of Tetrabenazine
QbD Pharmaceuticals Launches TETREN — Nepal’s First National Brand of Tetrabenazine
QbD Pharmaceuticals Pvt. Ltd. proudly announces the launch of TETREN (Tetrabenazine) 25 mg Tablets, marking another milestone in its continuing legacy of introducing new molecules and specialized therapeutic options to Nepal.
TETREN, containing Tetrabenazine 25 mg, is a VMAT2 inhibitor indicated for the management of chorea associated with Huntington’s disease. The launch reflects QbD Pharmaceuticals’ ongoing c
Product updates
